Review: Cholinesterase inhibitors have a modest effect on neuropsychiatric and functional outcomes in Alzheimer's disease: Commentary

Evidence-Based Mental Health

Volumn 6, Issue 3, 2003, Pages 94-

  Lahiri, Debomoy K ^a   Farlow, Martin R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79960440328     PISSN: 13620347     EISSN: None     Source Type: Journal    
DOI: 10.1136/ebmh.6.3.94     Document Type: Note

References (3)

1. Cummings JL. Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations. Am J Geriatr Psychiatry 2003; 11: 131-145. (Pubitemid 36254187)
2. Lahiri DK, Farlow MR, Greig NH et al. A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease. Curr Drug Targets 2003; 4: 97-112. (Pubitemid 36553583)
3. Farlow MR, Lahiri DK, Poirier J et al. Treatment outcome of tacrine therapy depends on Apolipoprotein genotype and gender of the subjects with Alzheimer's disease. Neurology 1998; 50: 669-77.